Alergologia Polska - Polish Journal of Allergology

Oral immunotherapy as a treatment for patients with food allergies

Kamil Filiks 1, 2
,
Julia Jarzabek 1
,
Rafał Pawliczak 1

  1. Department of Immunopathology, Faculty of Medicine, Medical University of Lodz, Poland

  2. Department of Molecular Biology, Faculty of Medicine, Medical University of Lodz, Poland

Alergologia Polska – Polish Journal of Allergology

DOI: https://doi.org/10.5114/pja.2026.163797
Data publikacji online: 2026/08/03
Article file
PJA Oral.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Spolidoro GCI, Amera YT, Ali MM, et al. Frequency of food allergy in Europe: an updated systematic review and meta-analysis. Allergy 2023; 78: 351-68.
  2. Liu AH, Jaramillo R, Sicherer SH, et al. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol 2010; 126: 798-806.e13.
  3. Tedner SG, Asarnoj A, Thulin H, et al. Food allergy and hypersensitivity reactions in children and adults – a review. J Intern Med 2022; 291: 283-302.
  4. Turnbull JL, Adams HN, Gorard DA. Review article: the diagnosis and management of food allergy and food intolerances. Aliment Pharmacol Ther 2015; 41: 3-25. 4 5.
  5. Shamji MH, Valenta R, Jardetzky T, et al. The role of allergen‐specific IgE, IgG and IgA in allergic disease. Allergy 2021; 76: 3627-41.
  6. Pasta A, Formisano E, Calabrese F, et al. Food intolerances, food allergies and IBS: lights and shadows. Nutrients 2024; 16: 265.
  7. Anvari S, Miller J, Yeh CY, Davis CM. IgE-mediated food allergy. Clin Rev Allergy Immunol 2019; 57: 244-60.
  8. Yu W, Freeland DMH, Nadeau KC. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol 2016; 16: 751-65.
  9. Francis OL, Wang KY, Kim EH, Moran TP. Common food allergens and cross-reactivity. J Food Allergy 2020; 2: 17-21.
  10. Warren CM, Otto AK, Walkner MM, Gupta RS. Quality of life among food allergic patients and their caregivers. Curr Allergy Asthma Rep 2016; 16: 38.
  11. Passalacqua G, Canonica GW, Bagnasco D. Benefit of SLIT and SCIT for allergic rhinitis and asthma. Curr Allergy Asthma Rep 2016; 16: 88.
  12. Feuille E, Nowak-Węgrzyn A. Oral immunotherapy for food allergies. Ann Nutr Metab 2016; 68 (Suppl. 1): 18-31.
  13. Kucuksezer UC, Ozdemir C, Cevhertas L, et al. Mechanisms of allergen-specific immunotherapy and allergen tolerance. Allergol Int 2020; 69: 549-60.
  14. Cuppari C, Leonardi S, Manti S, et al. Allergen immunotherapy, routes of administration and cytokine networks: an update. Immunotherapy 2014; 6: 775-86.
  15. Jutel M, Klimek L, Richter H, et al. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control – A RWE study. Allergy 2024; 79: 1042-51.
  16. Heeringa JJ, McKenzie CI, Varese N, et al. Induction of IgG2 and IgG4 B‐cell memory following sublingual immunotherapy for ryegrass pollen allergy. Allergy 2020; 75: 1121-32.
  17. Ren L, Wang C, Xi L, et al. Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis. Allergy Asthma Clin Immunol 2023; 19: 20.
  18. Fritzsching B, Contoli M, Porsbjerg C, et al. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: results from the REACT study, a retrospective cohort study. Lancet Reg Health Eur 2022; 13. 100275.
  19. Lam HY, Tergaonkar V, Ahn KS. Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies. Biosci Rep 2020; 40: BSR20200256.
  20. Kenison JE, Stevens NA, Quintana FJ. Therapeutic induction of antigen-specific immune tolerance. Nat Rev Immunol 2024; 24: 338-57.
  21. Akdis M, Aab A, Altunbulakli C, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2016; 138: 984-1010.
  22. Santos MCP, Serra-Caetano A, Pedro E, et al. Expansion of FOXP3+ regulatory CD4 T cells upon exposure to hymenoptera venom during the beekeeping season. Allergy 2019; 74: 1182-4.
  23. Akdis M, Aab A, Altunbulakli C, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: receptors, functions, and roles in diseases. J Allergy Clin Immunol 2016; 138: 984-1010.
  24. Boonpiyathad T, Meyer N, Moniuszko M, et al. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers. Allergy 2017; 72: 407-15.
  25. Santos AF, James LK, Bahnson HT, et al. IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens. J Allergy Clin Immunol 2015; 135: 1249-56.
  26. Celebi Sözener Z, Mungan D, Cevhertas L, et al. Tolerance mechanisms in allergen immunotherapy. Curr Opin Allergy Clin Immunol 2020; 20: 591.
  27. Ihara F, Sakurai D, Yonekura S, et al. Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy. Allergy 2018; 73: 1823-32.
  28. Patil VK, Kurukulaaratchy RJ, Venter C, et al. Changing prevalence of wheeze, rhinitis and allergic sensitisation in late childhood: findings from 2 Isle of Wight birth cohorts 12 years apart. Clin Exp Allergy 2015; 45: 1430-8.
  29. Siddiqui Z, Walker A, Pirwani M, et al. Allergic rhinitis: diagnosis and management. Br J Hosp Med 2022; 83: 1-9.
  30. Linton S, Burrows AG, Hossenbaccus L, Ellis AK. Future of allergic rhinitis management. Ann Allergy Asthma Immunol 2021; 127: 183-90.
  31. Nakagome K, Nagata M. Allergen immunotherapy in asthma. Allergol Int 2024; 73: 487-93.
  32. Passalacqua G, Canonica GW, Bagnasco D. Benefit of SLIT and SCIT for allergic rhinitis and asthma. Curr Allergy Asthma Rep 2016; 16: 88.
  33. Yang J, Lei S. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis. Front Immunol 2023; 14: 1274241.
  34. Asiri A, Alzahrani F, Ismail GM, et al. Efficacy and safety of sublingual and subcutaneous immunotherapy in children with allergic rhinitis: a systematic review of randomized trials including direct and indirect comparisons. Int J Gen Med 2025; 18: 7037-47.
  35. Contoli M, Porsbjerg C, Buchs S, et al. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: subgroup analyses of the REACT study. J Allergy Clin Immunol 2023; 152: 445-52.e4.
  36. Hamada M, Saeki K, Tanaka I. Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: a prospective cohort study. Allergol Int 2023; 72: 573-9.
  37. Wahn U, Bachert C, Heinrich J, et al. Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma. Allergy 2019; 74: 594-604.
  38. He Y, Liu X, Zhou B, Dai T. Efficacy of different allergen-specific immunotherapies for the treatment of allergic rhinitis in children and adults: an umbrella review. Front Immunol 2025; 16: 1658826.
  39. Cook LM, Longfellow GA, Kessel JC, et al. Direct comparison of quality of life in patients with allergic rhinitis undergoing sublingual versus subcutaneous immunotherapy. J Clin Med 2024; 13: 6397.
  40. Brüggenjürgen B, Reinhold T. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland. J Med Econ 2018; 21: 374-81.
  41. Hardin FM, Eskander PN, Franzese C. Cost-effective analysis of subcutaneous vs sublingual immunotherapy from the payor’s perspective. OTO Open 2021; 5: 2473974X211052955.
  42. Wood R. Oral immunotherapy for food allergy. J Investig Allergol Clin Immunol 2017; 27: 151-9.
  43. Mori F, Giovannini M, Barni S, et al. Oral immunotherapy for food-allergic children: a pro-con debate. Front Immunol 2021; 12: 636612.
  44. The PALISADE Group of Clinical Investigators. AR101 oral immunotherapy for peanut allergy. N Engl J Med 2018; 379: 1991-2001.
  45. Calatayud CM, García AM, Aragonés AM, De La Hoz Caballer B. Safety and efficacy profile and immunological changes associated with oral immunotherapy for IgE-mediated cow’s milk allergy in children: systematic review and meta-analysis. J Investig Allergol Clin Immunol 2014; 24: 298-307.
  46. Vázquez-Cortés S, Jaqueti P, Arasi S, et al. Safety of food oral immunotherapy: what we know, and what we need to learn. Immunol Allergy Clin North Am 2020; 40: 111-33.
  47. Wasserman RL, Hague AR, Pence DM, et al. Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients. J Allergy Clin Immunol Pract 2019; 7: 418-26.e4.
  48. Mori F, Barni S, Liccioli G, Novembre E. Oral immunotherapy (OIT): a personalized medicine. Medicina (Mex) 2019; 55: 684.
  49. Alkhowaiter S. Eosinophilic esophagitis. Saudi Med J 2023; 44: 640-6.
  50. Blumchen K, Trendelenburg V, Ahrens F, et al. Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol Pract 2019; 7: 479-91.e10.
  51. Fauquert JL, Michaud E, Pereira B, et al. Peanut gastrointestinal delivery oral immunotherapy in adolescents: results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study). Clin Exp Allergy 2018; 48: 862-74.
  52. Burks AW, Wood RA, Jones SM, et al. Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol 2015; 135: 1240-8.e1-3.
  53. Kim EH, Keet CA, Virkud YV, et al. Open-label study of the efficacy, safety and durability of peanut sublingual immunotherapy in peanut-allergic children. J Allergy Clin Immunol 2023; 151: 1558-65.e6.
  54. Maeda M, Imai T, Ishikawa R, et al. Effect of oral immunotherapy in children with milk allergy: the ORIMA study. Allergol Int 2021; 70: 223-8.
  55. Dantzer J, Dunlop J, Psoter KJ, et al. Efficacy and safety of baked milk oral immunotherapy in children with severe milk allergy: a randomized, double-blind, placebo-controlled phase 2 trial. J Allergy Clin Immunol 2022; 149: 1383-91.e17.
  56. Esmaeilzadeh H, Alyasin S, Haghighat M, et al. The effect of baked milk on accelerating unheated cow’s milk tolerance: a control randomized clinical trial. Pediatr Allergy Immunol 2018; 29: 747-53.
  57. Gaspar Â, Piedade S, Monteiro-Marques C, et al. Cow’s milk oral immunotherapy in real-life: up to 15-year follow-up study. Eur Ann Allergy Clin Immunol 2026 Jan 16. doi:10.23822/EurAnnACI.1764-1489.424
  58. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012; 129: 448-55.e5.
  59. Giavi S, Vissers YM, Muraro A, et al. Oral immunotherapy with low allergenic hydrolysed egg in egg allergic children. Allergy 2016; 71: 1575-84.
  60. Escudero C, Rodríguez Del Río P, Sánchez‐García S, et al. Early sustained unresponsiveness after short‐course egg oral immunotherapy: a randomized controlled study in egg‐allergic children. Clin Exp Allergy 2015; 45: 1833-43.
  61. Akashi M, Yasudo H, Narita M, et al. Randomized controlled trial of oral immunotherapy for egg allergy in Japanese patients. Pediatr Int 2017; 59: 534-9.
  62. Lloyd M, Loke P, Nguyen K, et al. Probiotic oral immunotherapy for egg and milk allergy induces sustained unresponsiveness. Pediatr Allergy Immunol 2025; 36: e70222.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications